Cargando…
Multiphysics pharmacokinetic model for targeted nanoparticles
Nanoparticles (NP) are being increasingly explored as vehicles for targeted drug delivery because they can overcome free therapeutic limitations by drug encapsulation, thereby increasing solubility and transport across cell membranes. However, a translational gap exists from animal to human studies...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335923/ https://www.ncbi.nlm.nih.gov/pubmed/35909883 http://dx.doi.org/10.3389/fmedt.2022.934015 |
_version_ | 1784759438493614080 |
---|---|
author | Glass, Emma M. Kulkarni, Sahil Eng, Christina Feng, Shurui Malaviya, Avishi Radhakrishnan, Ravi |
author_facet | Glass, Emma M. Kulkarni, Sahil Eng, Christina Feng, Shurui Malaviya, Avishi Radhakrishnan, Ravi |
author_sort | Glass, Emma M. |
collection | PubMed |
description | Nanoparticles (NP) are being increasingly explored as vehicles for targeted drug delivery because they can overcome free therapeutic limitations by drug encapsulation, thereby increasing solubility and transport across cell membranes. However, a translational gap exists from animal to human studies resulting in only several NP having FDA approval. Because of this, researchers have begun to turn toward physiologically based pharmacokinetic (PBPK) models to guide in vivo NP experimentation. However, typical PBPK models use an empirically derived framework that cannot be universally applied to varying NP constructs and experimental settings. The purpose of this study was to develop a physics-based multiscale PBPK compartmental model for determining continuous NP biodistribution. We successfully developed two versions of a physics-based compartmental model, models A and B, and validated the models with experimental data. The more physiologically relevant model (model B) had an output that more closely resembled experimental data as determined by normalized root mean squared deviation (NRMSD) analysis. A branched model was developed to enable the model to account for varying NP sizes. With the help of the branched model, we were able to show that branching in vasculature causes enhanced uptake of NP in the organ tissue. The models were solved using two of the most popular computational platforms, MATLAB and Julia. Our experimentation with the two suggests the highly optimized ODE solver package DifferentialEquations.jl in Julia outperforms MATLAB when solving a stiff system of ordinary differential equations (ODEs). We experimented with solving our PBPK model with a neural network using Julia's Flux.jl package. We were able to demonstrate that a neural network can learn to solve a system of ODEs when the system can be made non-stiff via quasi-steady-state approximation (QSSA). Our model incorporates modules that account for varying NP surface chemistries, multiscale vascular hydrodynamic effects, and effects of the immune system to create a more comprehensive and modular model for predicting NP biodistribution in a variety of NP constructs. |
format | Online Article Text |
id | pubmed-9335923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93359232022-07-30 Multiphysics pharmacokinetic model for targeted nanoparticles Glass, Emma M. Kulkarni, Sahil Eng, Christina Feng, Shurui Malaviya, Avishi Radhakrishnan, Ravi Front Med Technol Medical Technology Nanoparticles (NP) are being increasingly explored as vehicles for targeted drug delivery because they can overcome free therapeutic limitations by drug encapsulation, thereby increasing solubility and transport across cell membranes. However, a translational gap exists from animal to human studies resulting in only several NP having FDA approval. Because of this, researchers have begun to turn toward physiologically based pharmacokinetic (PBPK) models to guide in vivo NP experimentation. However, typical PBPK models use an empirically derived framework that cannot be universally applied to varying NP constructs and experimental settings. The purpose of this study was to develop a physics-based multiscale PBPK compartmental model for determining continuous NP biodistribution. We successfully developed two versions of a physics-based compartmental model, models A and B, and validated the models with experimental data. The more physiologically relevant model (model B) had an output that more closely resembled experimental data as determined by normalized root mean squared deviation (NRMSD) analysis. A branched model was developed to enable the model to account for varying NP sizes. With the help of the branched model, we were able to show that branching in vasculature causes enhanced uptake of NP in the organ tissue. The models were solved using two of the most popular computational platforms, MATLAB and Julia. Our experimentation with the two suggests the highly optimized ODE solver package DifferentialEquations.jl in Julia outperforms MATLAB when solving a stiff system of ordinary differential equations (ODEs). We experimented with solving our PBPK model with a neural network using Julia's Flux.jl package. We were able to demonstrate that a neural network can learn to solve a system of ODEs when the system can be made non-stiff via quasi-steady-state approximation (QSSA). Our model incorporates modules that account for varying NP surface chemistries, multiscale vascular hydrodynamic effects, and effects of the immune system to create a more comprehensive and modular model for predicting NP biodistribution in a variety of NP constructs. Frontiers Media S.A. 2022-07-15 /pmc/articles/PMC9335923/ /pubmed/35909883 http://dx.doi.org/10.3389/fmedt.2022.934015 Text en Copyright © 2022 Glass, Kulkarni, Eng, Feng, Malaviya and Radhakrishnan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medical Technology Glass, Emma M. Kulkarni, Sahil Eng, Christina Feng, Shurui Malaviya, Avishi Radhakrishnan, Ravi Multiphysics pharmacokinetic model for targeted nanoparticles |
title | Multiphysics pharmacokinetic model for targeted nanoparticles |
title_full | Multiphysics pharmacokinetic model for targeted nanoparticles |
title_fullStr | Multiphysics pharmacokinetic model for targeted nanoparticles |
title_full_unstemmed | Multiphysics pharmacokinetic model for targeted nanoparticles |
title_short | Multiphysics pharmacokinetic model for targeted nanoparticles |
title_sort | multiphysics pharmacokinetic model for targeted nanoparticles |
topic | Medical Technology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335923/ https://www.ncbi.nlm.nih.gov/pubmed/35909883 http://dx.doi.org/10.3389/fmedt.2022.934015 |
work_keys_str_mv | AT glassemmam multiphysicspharmacokineticmodelfortargetednanoparticles AT kulkarnisahil multiphysicspharmacokineticmodelfortargetednanoparticles AT engchristina multiphysicspharmacokineticmodelfortargetednanoparticles AT fengshurui multiphysicspharmacokineticmodelfortargetednanoparticles AT malaviyaavishi multiphysicspharmacokineticmodelfortargetednanoparticles AT radhakrishnanravi multiphysicspharmacokineticmodelfortargetednanoparticles |